Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-24-038599
Filing Date
2024-09-27
Accepted
2024-09-27 17:17:10
Documents
5
Effectiveness Date
2024-09-27

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 78103
2 ex5-1.htm EX-5.1 16536
3 ex23-1.htm EX-23.1 4215
4 ex107.htm EX-FILING FEES 23946
5 ex5-1_01.jpg GRAPHIC 22655
  Complete submission text file 0001493152-24-038599.txt   155146
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-282391 | Film No.: 241335987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)